These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21152247)

  • 21. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
    Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
    J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic neuron injury in Parkinson's disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/ α-synuclein pathway.
    Zhang LM; Wang MH; Yang HC; Tian T; Sun GF; Ji YF; Hu WT; Liu X; Wang JP; Lu H
    Aging (Albany NY); 2019 Nov; 11(21):9264-9279. PubMed ID: 31683259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease.
    Kalivendi SV; Yedlapudi D; Hillard CJ; Kalyanaraman B
    Free Radic Biol Med; 2010 Feb; 48(3):377-83. PubMed ID: 19857570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
    Choong CJ; Say YH
    Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-α-synuclein Toxicity and Anti-neurodegenerative Role of Chrysin in Transgenic
    Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
    ACS Chem Neurosci; 2022 Feb; 13(4):442-453. PubMed ID: 35118868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics.
    Javed H; Kamal MA; Ojha S
    CNS Neurol Disord Drug Targets; 2016; 15(10):1240-1252. PubMed ID: 27658511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
    George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
    J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4E-BP1 Protects Neurons from Misfolded Protein Stress and Parkinson's Disease Toxicity by Inducing the Mitochondrial Unfolded Protein Response.
    Dastidar SG; Pham MT; Mitchell MB; Yeom SG; Jordan S; Chang A; Sopher BL; La Spada AR
    J Neurosci; 2020 Nov; 40(45):8734-8745. PubMed ID: 33046555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
    Lee SH; Han YT; Cha DS
    Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
    Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
    Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.
    Monti B; Gatta V; Piretti F; Raffaelli SS; Virgili M; Contestabile A
    Neurotox Res; 2010 Feb; 17(2):130-41. PubMed ID: 19626387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P75 Involved in the Ubiquitination of α-synuclein in Rotenone-based Parkinson's Disease Models.
    Chen Y; Hou Y; Yang J; Du R; Chen C; Chen F; Wang H; Ge R; Chen J
    Neuroscience; 2018 Sep; 388():367-373. PubMed ID: 30081046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATP depletion is the major cause of MPP+ induced dopamine neuronal death and worm lethality in alpha-synuclein transgenic C. elegans.
    Wang YM; Pu P; Le WD
    Neurosci Bull; 2007 Nov; 23(6):329-35. PubMed ID: 18064062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion in exon 5 of the SNCA gene and exposure to rotenone leads to oligomerization of α-synuclein and toxicity to PC12 cells.
    Ma KL; Song LK; Long WA; Yuan YH; Zhang Y; Song XY; Niu F; Han N; Chen NH
    Brain Res Bull; 2013 Jan; 90():127-31. PubMed ID: 23128054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.